
GB40314
Palbociclib 2HCl
Also listed as PD 0332991 hydrochloride - Palbociclib hydrochloride
An orally active cyclin-dependent kinase (CDK) inhibitor, specifically targeting on CDK4 and CDK6; a potential agent for the treatment of breast cancer; water soluble hydrochloride salt form, ideal for in vivo experiments· Another salt form, PD 0332991 isethionate is also available·Prime Source Information: The molecule of PD0332991 contains multiple basic nitrogens, which could form 1 to 4 eq HCl salt of PD0332991 and its accurate salt form has been determined by microanalysis and specified on certificate of analysis (COA) of every batch of our samples
- CAS number
- 1831842-69-3
- Molecular weight
- 520.45
- Formula
- C24H29N7O2·2HCl
- InChIKey
- YORIVNBSTFKZTO-UHFFFAOYSA-N
- Catalogue number
- GB40314
- Brand
- GLPBIO
Computed properties PubChem CID 60167560 · TPSA 103 Ų · H-bond donors 4 · H-bond acceptors 8
- TPSA
- 103 Ų
- H-bond donors
- 4
- H-bond acceptors
- 8
- Rotatable bonds
- 5
- Heavy atoms
- 35
SMILES CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C.Cl.Cl
Computed descriptors from PubChem (CID 60167560), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il